scholarly article | Q13442814 |
P2093 | author name string | Shinya Fukumoto | |
Hidetomo Iwano | |||
Kiwamu Hanazono | |||
Tsuyoshi Kadosawa | |||
Tsuyoshi Uchide | |||
Yoshifumi Endo | |||
Yoshio Kawamura | |||
P2860 | cites work | FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression | Q33850413 |
Canine transitional cell carcinoma | Q35102632 | ||
Management of transitional cell carcinoma | Q35173824 | ||
The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors | Q35640292 | ||
Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis | Q35979121 | ||
The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients | Q36614287 | ||
Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs | Q36692592 | ||
The role of the EGFR signaling in tumor microenvironment. | Q36951215 | ||
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer | Q37655607 | ||
Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer | Q37827953 | ||
Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis | Q39375935 | ||
Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours | Q39704301 | ||
Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer | Q40532768 | ||
Polypoid cystitis in 17 dogs (1978-2001). | Q40571196 | ||
Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression | Q40835141 | ||
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer | Q42809167 | ||
Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours | Q44877290 | ||
Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer | Q45274822 | ||
Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. | Q47740831 | ||
Usefulness of epidermal growth factor receptor and p53 cocktail immunostaining for differential diagnosis with urine cytology. | Q51795252 | ||
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. | Q51925963 | ||
The epidermal growth factor receptor mediates radioresistance. | Q52011134 | ||
Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985) | Q68186232 | ||
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours | Q69856767 | ||
Long-term outcome related to epidermal growth factor receptor status in bladder cancer | Q72539394 | ||
Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer | Q73311092 | ||
C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer | Q73738001 | ||
Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer | Q78175120 | ||
P433 | issue | 1 | |
P921 | main subject | transitional cell carcinoma | Q2501186 |
P304 | page(s) | 1-6 | |
P577 | publication date | 2014-09-16 | |
P1433 | published in | Journal of Veterinary Medical Science | Q15753254 |
P1476 | title | Epidermal growth factor receptor expression in canine transitional cell carcinoma | |
P478 | volume | 77 |
Q35767570 | Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer. |
Q45887469 | Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro |
Q58765944 | EGF Level in Hepatoid Gland Adenomas and Hepatoid Gland Epitheliomas in Dogs After Administering Tamoxifen |
Q36034972 | Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells |
Q33593041 | Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs. |
Q55081994 | Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies. |
Q89622453 | Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans |